Alex Green’s “Next Magnificent 7” Stocks Revealed

Alexander Green of The Oxford Club has released a new 2024 presentation recommending seven stocks he calls the “Next Magnificent 7.”

According to Green, a small $7,000 portfolio of these “seven little-known stocks” could make you a “millionaire in less than six years.”

That’s a bold claim.

But Alex Green has picked some great stocks over the years, and he is one of the more credible “gurus” in the newsletter space.

So, I did some research to find out what companies he is recommending (and why), and in this post, I’ll show you what I found (including the names and tickers of his picks).

Overview of Alexander Green’s AI Prediction

Before we get into the specific stocks Alex Green is recommending, let’s take a moment to unpack his overall investment thesis, which centers around artificial intelligence (AI).

In short, Alex Green believes that AI is the “most important wealth-building opportunity since the internet.”

And that’s where the whole “Magnificent 7” thing comes into play.

As Green explains in the presentation, the seven stocks that have dominated the market for the past two decades are tech companies that have benefited from the rise of the internet.

Namely:

• Google
• Microsoft
• Apple
• Amazon
• Nvidia
• META
• Tesla

However, Green believes that AI is bigger than the personal computer, smartphone, and internet, making it a potentially much larger opportunity for investors.

“AI, quite simply, is just as big, perhaps bigger than the personal computer, the smartphone, and yes even the internet.”

Source: https://web.archive.org/web/20240823005952/https://pro.oxfordclub.com/p/SEVENTO59OXFLT2YRDSMAL/WOXF4710/?h=true&displaytranscript=1

As always, I would recommend taking presentations like this with a pinch of salt because a lot of what is said is hype used to sell newsletter subscriptions.

In this case, Green is selling a $49 subscription to The Oxford Communique.

That said, there’s no doubt that AI is a big deal.

In fact, it’s expected to add trillions to the global economy in the years ahead, and some stocks will benefit more than others as this all plays out.

Does that mean Alex Green’s “next magnificent 7” stocks will make you rich?

Not necessarily, no.

Just like in the early days of the Internet, many promising companies failed, and even the ones that survived and thrived experienced a lot of volatility in their stock price.

Nevertheless, Alex Green claims to have spent months working on identifying the companies that could help everyday investors turn a $7,000 portfolio ($1,000 invested in each company) into a millionaire in as little as six years.

“I’ve spent the last few months working to identify exactly which companies I believe will become the new household names.

“The ones that will be synonymous with AI…

“The same way that Apple, Amazon, Google, Microsoft, Tesla, META, and Nvidia dominated the age of the internet.

“And through my research, I’ve found the exact seven stocks you need to buy right now.”

[…]

“I believe they will be crowned ‘The Next Magnificent Seven.'”

[…]

“And I believe that if you put a small investment in these seven companies, as little as $1,000 in each… you could become a millionaire in under six years.”

Again, that’s a very bold claim. And it’s one I recommend taking with a grain of salt because no one knows what will happen with the price of ANY stock.

But I wanted to know what he was teasing, so I looked into his clues to figure out what his seven picks were. And in the next section, I’ll break each pick down for you (so you don’t have to join his paid newsletter to find out what they are).

The “Next Magnificent 7” Stocks Revealed

Stock #1 (Arm Holdings)

Alexander Green’s first pick is a company that he says designs, develops, and licenses high-performance central processing units (CPUs):

“The first stock that I am certain will become one of ‘The Next Magnificent Seven’ is one of the most important AI innovators in the world today.

“They design, develop, and license high performance central processing units or CPUs – the brain of any AI computing device.”

Here’s an overview of the specific clues he shared about this company:

“The company only IPO’d in 2023… but already people are openly wondering if it will become the next trillion-dollar company.

“The company has its advanced CPU technology in over 280 billion chips in ‘everything from sensors to smartphones to servers.'”

[…]

“The company just entered into a MASSIVE long-term deal with Apple… to ensure this company’s chip technology will be found in both iPhones and Macbooks until… get this… 2040!”

[…]

“Nvidia is loading up on shares. So is Apple, Google, AMD, Intel, and Samsung.

“They are all now invested in this company directly.”

So, we know it’s a company in the CPU industry that IPO’d in 2023, one that has a partnership with Apple, and major tech companies are loading up on its shares.

Aside from that, Green described how the company’s technology is being used and said it earns “recurring royalties” whenever a company uses its tech.

“Its tech is being used in AI found in new self-driving technology.

“It’s being used for cybersecurity AI, graphics and multimedia AI, software and development AI…”

[…]

“Every time it gets its technology into something like an iPhone or a Nvidia superchip, the company earns recurring royalties.

“Royalties represent about 60% of the company’s business.”

What could it be?

It looks like Alex Green’s first pick is Arm Holdings (ARM):

Here’s a quick overview of why:

• Arm Holdings is known for designing and licensing high-performance CPUs, which are used in a range of devices, including smartphones and servers.
• Arm Holdings IPO’d (went public) in September 2023.
• According to this article on Forbes, Arm has shipped over 280 billion chips since the 1980s.
• According to CNBC, Arm has struck a deal with Apple through 2024 and beyond.
• Arm’s business model centers around licensing its technology, earning royalties whenever it is used.

For these reasons, Arm Holdings appears to be Alex Green’s first pick.

Stock #2 (Cloudflare)

Green’s second pick is a company that he claims is “reinventing the internet with AI.”

He explains that powering all the new AI servers will require an immense amount of network power, and that’s where his second pick comes into play.

According to Green, the company has more than 300 data centers around the world, and its network speed is the fastest in most of the world:

“Thanks to an array of more than 300 data centers located in cities across the world… it is building one of the fastest and safest information networks our world has ever seen.

“In fact, it’s speed dwarfs its nearest competitors… Amazon and Google.

“And it is now the fastest network provider in most of the world’s countries.”

As for more specific clues about the stock, Green shed light on its customers and income and shared a quote from the CEO about the company’s products:

IBM, H&M, Doordash, Walmart, Best Buy, Lenovo, Dell, Etsy, and Nike now work with this company.

In fact, 30% of the Fortune 1000 companies are now customers.

[…]

The company topped Wall Street estimates by 79% on average over the last four quarters.

In the third quarter, net income improved 167% on a 32% increase in sales.

[…]

“Here’s what the CEO of the company had to say about its explosive growth.

“’The opportunity we have in front of us is enormous. We’ve penetrated less than 1% of our identified market for the products we have available today.’”

Based on those clues, this one is most likely Cloudflare (NET):

What does the company do?

Basically, Cloudflare helps make the internet more secure.

The company runs a large network of data centers worldwide, which helps make websites and applications faster, safer, and more reliable.

It aims to create a better internet that is more secure and efficient, and it’s also growing quickly in supporting AI infrastructure.

Stock #3 (Exscientia)

Alex Green’s third pick is an AI drug discovery company:

“The third ‘Next Magnificent Seven’ stock is one directly using AI to discover treatments for difficult diseases.

“It was founded by a doctor in biophysics from the University of Oxford.

“And this company is using AI to instantly sift through millions of drug candidates… pinpointing the ones that are most likely to treat any disease.”

And here’s a summary of the clues he shared about the stock:

“The stock trades for less than $10 now.”

[…]

“Sanofi recently agreed to pay the company up to $5.2 billion to develop 15 oncology and immunology drugs.”

[…]

“They also have a collaboration with Merck on three potential “best-in-class” drug targets worth up to $674 million.

“It signed a major $1.2 billion partnership with Bristol Meyers Squibb.

“It’s working with RallyBio, an American pharma company, on rare diseases.

“And Apeiron Therapeutics on ovarian cancer.

“I haven’t seen a biotech with this much upside potential since Intuitive Surgical… a company we wrote about back in 2004.”

What could this one be?

This stock appears to be Exscientia (EXAI), a UK-based pharmaceutical tech company that uses AI to design and develop new drugs.

The main clue that led me to that conclusion was the one about Sanofi agreeing to pay the company “up to $5.2 billion to develop 15 oncology and immunology drugs.”

That hint led me to a Bloomberg article, which describes the deal in more detail and confirms that the company Sanofi is working with is Exscientia PLC.

The other clues appear to line up as well.

So, Exscientia looks like a match.

And worth noting is that Green teased this stock last year as his #1 AI stock pick, so this is one he’s been bullish on for a while now.

Stock #4 (10x Genomics)

Green explains that his fourth pick is a company that helps detect and fix anomalies in the human body at a cellular level that can lead to disease.

According to Green, scientists use its machine to come up with treatments for Alzheimer’s disease, cystic fibrosis, and more.

“Each of us is made up of an average of 40 trillion individual cells.

“These cells are enormously complex.

“If everything is functioning perfectly, we enjoy good health.

“But if something is off – even a little bit – it can lead to disease.

“My fourth Next Magnificent Seven stock uses AI to discover and fix these problems at the cellular level.

“Scientists use its machines to research treatments for Alzheimer’s disease, cystic fibrosis, a number of cancers and many more diseases.”

He also shared some specific clues about patents the company has, the number of publications the company’s research has been cited in, and its sales figures.

“And our company has 1750 patents protecting its technology from competitors.”

[…]

“Its tools have been cited in over 5,000 publications… with the number growing each year.”

[…]

“The company went from $298 million in sales in 2020… to $618 million in sales last year.

“Their margins are huge too – at 66%.

“And they are sitting on a massive cash hoard of $359 million.”

Based on those hints, it looks like Green’s fourth pick is 10x Genomics (TXG), a U.S. biotech company that designs and manufactures gene sequencing technology.

From what I understand, 10x Genomics develops technologies that allow researchers to analyze biological systems at a cellular level, just like Green said, and this can lead to a better understanding of diseases like Alzheimer’s, cystic fibrosis, and various cancers.

So, not only does the company description line up with what Green said, but according to genesmart.vn, the company has over 1,750 patents (issued or filed) and has been cited in over 7,000 publications. And further research revealed that the revenue figures he mentioned from 2020 and last year (2023) align with 10x Genomics as well.

Stock #5 (Symbotic)

Stock number five on the list is an AI robotics company…

“Our 5^th ‘Next Magnificent Seven’ stock is a developer of AI software and robotics for supply chains in the United States.

“Its robots can navigate giant distribution centers at speeds up to 20 mph… stocking and retrieving goods in a fraction of the time compared to old technology.

“In short, it moves goods with unmatched speed, accuracy, and efficiency.

“And this AI company packages, stocks, and ships out goods for some of the biggest retailers in the world.”

According to Alex Green, the company works with the second largest grocery chain in North America (Albertson’s), is partners with Target, and has signed a deal with Walmart.

“The company works with Albertson’s, the second largest grocery chain in North America.

“It partners with Target, the seventh largest retailer in the country.

“But here’s the big one…

“It just signed a huge deal with Walmart, the #1 retailer in the country, to install systems in every one of Walmart regional distribution centers nationwide.”

He also dropped some hints about the company’s financials:

“Revenue already jumped 98% last year.

“But growth looks dramatically higher in the future.

“The company is in excellent financial position.

“With zero debt… and $675 million in cash.

“It’s no wonder that the insiders own 19% of outstanding shares.”

What’s this one?

I’d say this one is Symbotic (SYM):

Why?

Firstly, what the company does lines up with Green’s clues.

Symbotic specializes in using AI-powered robots and automation systems for managing supply chains, especially in large distribution centers.

Their robots can move and handle items quickly, which helps to make the process more efficient and accurate.

Second, Symbotic has well-known partnerships with major retailers, including Albertson’s, Target, and Walmart.

And lastly, as per Green’s hint, the company’s revenue almost doubled from 2022 to 2023.

So, Symbotic appears to be Alex Green’s fifth “Magnificent 7” pick.

Stock #6 (Cyberark Software)

Stock #6 is a cybersecurity company that Green says is “protecting us from the dangers of AI.”

“… our 6^th ‘Next Magnificent Seven’ company is using AI to fight these cyber-criminals.

“In short, they’ve built an AI technology that instantly authenticates and verifies authorized users.

“And it blocks the cybercriminals out.”

As for specific clues, here’s a summary of what Green said:

“The company provides cybersecurity for American Express, BP, Duestche Bank, UBS, Suncor, Metlife… even NASA!”

[…]

“Subscription revenue jumped from $280 million to $472 million… growth of 68% in a single year.

“Annual recurring revenue increased from $570 to $774 million

“The company is flush with cash, at $1.3 billion in the bank.”

This one is Cyberark Software (CYBR), a cybersecurity company specializing in identity security services that help protect against cyber threats.

Based on my research, the company provides cybersecurity services to many major companies and institutions, including the ones Alex Green mentioned.

I also found that the company’s revenue did increase to $774 million last year, thus matching another of Green’s hints.

So, Cyberark looks like a match.

Stock #7 (CRISPR Therapeutics)

Lastly, we have a biotech company specializing in gene-editing that Alex Green says is his “#1 stock in the entire market going into this year (2024)”.

Here’s what he had to say about this one:

“Ok, I saved the best for last.”

“The final ‘Next Magnificent Seven’ stock is also in biotech – because I’ve seen more opportunity there than in any other industry.

“And this is a stock I highlighted as my #1 stock in the entire market going into this year.

“The company operates in a new technology that was only invented just over 10 years ago.

“It’s called ‘gene-editing.’

“And it won the Nobel-prize for chemistry in 2011.”

The general idea behind gene-editing technology, at least from what I understand, is that it allows scientists to make changes to the DNA of living cells to create new treatments for genetic diseases. And according to the presentation, Green believes this tech is a “gift for the human race” that could lead to people living “longer, healthier, and happier lives.”

What company is he teasing here?

Here’s a summary of the clues he shared:

“And my favorite company is the first company ever to win full approval of a gene-editing drug.”

[…]

“The company has numerous treatments in the pipeline.

“It has two treatments in the works for cardiovascular disease.

“It is testing treatments for lymphoma, kidney cancer, and solid tumors.

“It’s working on a gene-editing treatment for diabetes.

“All told, the company expects to have 20 different treatments in the next five years.”

[…]

“In short, this company is on the cutting edge of a technology that will save millions of lives and make billions of dollars.

“I have no doubt it will become one of the most important household names in the market.”

So, based on that, we’re looking for a biotech company that was the first to be awarded “full approval of a gene-editing drug” and that has 20 different treatments in its pipeline.

What could it be?

This one appears to be CRISPR Therapeutics (CRSP), a Switzerland-based biotech company that utilizes gene editing technology to develop treatments for various diseases.

According to an article on fastcompany.com, a gene-editing treatment called Exa-cel (marketed as Casgevy) developed by Vertex Pharmaceuticals and CRISPR Therapeutics was the “first-ever CRISPR gene-editing treatment” to be approved by the FDA in 2023.

So, based on that, Alex Green’s pick could be either Vertex Pharmaceuticals or CRISPR Therapeutics. However, upon taking a closer look at the clues in the presentation, it looks like CRISPR Therapeutics is the company Green is teasing here.

I say that mostly because the company’s pipeline includes 20 new drugs, some of which are aimed at treating the diseases Green mentioned, and that was one of his main hints. But also because CRISPR Therapeutics is a stock the Oxford Club has teased before.

Bottom Line

There we have it… SEVEN of Alex Green’s 2024 stock picks!

Here’s a recap of Green’s “Next Magnificient 7” stocks:

• Arm Holdings (ARM)
• Cloudflare (NET)
• Exscientia (EXAI)
• 10x Genomics (TXG)
• Symbotic (SYM)
• Cyberark Software (CYBR)
• CRISPR Therapeutics (CRSP)

I can’t say with 100% certainty that I’m right about every one of these, but I spent quite a bit of time researching his clues, and I’m confident I’m on the money here.

Either way, take the presentation with a pinch of salt… Alex Green’s claim that his seven stock picks could help you turn $7k into millions of dollars is a very bold one.

In fact, this is quite an overhyped statement.

He could be right, of course, especially since he has picked/recommended some really decent stocks in the past. But there’s no way to accurately predict which of these stocks (if any) will make you money – let alone millions.

And that’s why it’s always worth doing your own research before rushing into anything.

In any case, I hope you found this post helpful.

At least now you don’t have to spend $49 joining his newsletter, The Oxford Communique, just to find out which companies he’s teasing. Because that’s the only way to access the report Green put together detailing his seven picks (the one called “The NEXT Magnificent Seven: How These Seven AI Stocks Could Make You a Millionaire).”

If you are considering joining that service, though, be sure to check out my review of The Oxford Communique, as I joined the service a while back and break down what it’s about, how it works, and how Alex Green’s stock picks have performed.

Anyway, that’s it from me. Thanks for stopping by, and if you’d like to comment on anything I’ve discussed in this post, feel free to chime in below.